Ecstasy: A common cause of severe acute hepatotoxicity
References (16)
- et al.
Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”)
Lancet
(1992) - et al.
Classifying acute liver failure
Lancet
(1993) - et al.
Liver transplantation for acute liver failure: analysis of applicability
Gastroenterology
(1993) - et al.
Acute liver damage and ecstasy ingestion
Gut
(1996) - et al.
Ecstasy-induced hepatitis mimicking viral hepatitis
Gut
(1995) - et al.
Hepatitis aguda tras consumo de éxtasis
Rev Esp Enf Digest
(1995) - et al.
Liver transplantation for the treatment of fulminant hepatic failure induced by ingestion of ecstasy
Transpl Int
(1997) - et al.
Epidemiología del consumo de drogas de diseño en España
Med Clín (Barcelona)
(1997)
Cited by (178)
Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral
2023, International Journal of Drug PolicyEmpfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden
2023, International Journal of Drug PolicyRecommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injection
2023, International Journal of Drug PolicyGut microbiota mediates methamphetamine-induced hepatic inflammation via the impairment of bile acid homeostasis
2022, Food and Chemical ToxicologyCitation Excerpt :Statistics reveal that in 2019, approximately 27 million people (0.5% of the global population) reported using Meth (Zeng et al., 2021), which has been a global public health challenge (Courtney and Ray, 2014; Chomchai and Chomchai, 2015). In addition to the severe neurotoxicity (Tan et al., 2020), clinical evidence suggests that both chronic and acute Meth abuse can cause hepatic damage, even liver failure (Andreu et al., 1998; Kamijo et al., 2002; Volkow et al., 2010; Eskandari et al., 2014), which is a common cause of acute toxic hepatitis in adults (Dahshan, 2009). Meth-induced hepatotoxic consequences involve complex mechanisms, including metabolic dysfunction, mitochondrial impairment, abnormal elevation of biogenic amines, and hyperthermia (Willson, 2019).
MDMA consumption in binge drinking situation: About a non-fatal case
2021, Toxicologie Analytique et CliniqueMephedrone and MDMA: A comparative review
2020, Brain ResearchCitation Excerpt :MDMA has been associated with several adverse health outcomes, with liver damage being reported multiple times. Research based on an intensive care liver unit investigated the frequency of MDMA-induced liver damage (Andreu et al., 1998). Between the years of 1994 to 1996, 8% of the individuals who were admitted to the unit suffered from MDMA-induced acute liver failure, being the second most common cause of liver damage for individuals under 25-years-of-age.